dr. tolaney on the current treatment landscape for her2 breast cancer
Published 7 years ago • 134 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
1:20
dr tolaney on ongoing clinical trials in early-stage her2 breast cancer
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
1:48
dr. tolaney on the evolution of adjuvant treatment for her2 breast cancer
-
1:32
dr. tolaney on the evolution of treatment in her2 breast cancer
-
1:20
dr tolaney on the potential role for biomarkers in early-stage her2 breast cancer
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
1:19
dr. lin on the treatment landscape in her2 metastatic breast cancer
-
1:42
treatment landscape for her2-positive breast cancer
-
2:06
dr. tolaney on deescalating therapy in stage i her2 breast cancer
-
1:39
dr tolaney on standard frontline treatment approaches in her2 breast cancer
-
1:53
dr. tolaney on navigating adjuvant therapy in early-stage her2 breast cancer
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
1:23
dr. burstein on the treatment landscape of her2 breast cancer
-
2:00
dr. mitri on the treatment landscape of her2 breast cancer
-
3:48
her2 breast cancer: future treatment landscape
-
1:55
dr. tolaney on abemaciclib plus pembrolizumab for hr , her2- breast cancer
-
1:00
dr. tolaney on remaining questions with cdk4/6 inhibitors in hr /her2- breast cancer